Skip to content

Daydream: training in relaxation and attentional focusing; a pilot study

Daydream: training in relaxation and attentional focusing; a pilot study - Daydream

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON38846
Enrollment
15
Registered
2013-09-03
Start date
2014-01-08
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia

Interventions

A training period of 10 days will be offered. The game will be played for 10 minutes twice a day. The patient is seated behind a computer, wearing a lightweight, wireless headset with one dry sensor

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Signed informed consent form - DSM-IV diagnosis schizofrenia, schizofreniform disorder, schizoaffective disorder or psychose NAO. - Age 18-30 years

Exclusion criteria

Exclusion criteria: - patients who are not capable to understand the study outline and/or provide written informed consent. - patients who are coercively admitted to the ward will not be invited to participate - Conditions placing patients at risk according to the judgment of the clinical staff, such as severe anxiety, behavioral problems, medical conditions, etc. - patients who use more than 6 mg lorazepam a day (or equivalent dosage of other benzodiazepines)

Design outcomes

Primary

MeasureTime frame
To investigate whether psychotic patients are able to play the game, reach the target level and improve over time, the game results will be evaluated (duration to reach/maintain the target level and improvement over time). User experience will be evaluated with short questionnaires.

Secondary

MeasureTime frame
User feedback will be used to improve the game or adapt game settings. Results will also be used to choose which conditions will be used in a subsequent study and to calculate sample size for a larger randomized control study.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)